Atom Investors LP Veracyte, Inc. Transaction History

Atom Investors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $73,248 - $101,500	3,488 Added 7.3%	51,287 $1.14 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $310,590 - $451,710	-15,750 Reduced 24.78%	47,799 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $378,158 - $506,695	16,935 Added 36.33%	63,549 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $42,569 - $54,816	2,031 Added 4.56%	46,614 $1.19 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $917,518 - $1.24 Million	44,583 New	44,583 $994,000
Q3 2022 Nov 08, 2022	BUY	$16.58 - $27.9 $300,529 - $505,715	18,126 New	18,126 $301,000
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $1.55 Million - $2.23 Million	-79,396 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $1.71 Million - $3.2 Million	-106,120 Reduced 57.2%	79,396 $2 Million
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $353,634 - $510,369	17,018 Added 10.1%	185,516 $5.18 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $618,591 - $801,550	25,915 Added 18.18%	168,498 $4.04 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $9.86 Million - $12.7 Million	-446,305 Reduced 75.79%	142,583 $4.07 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $1.19 Million - $2.55 Million	98,811 Added 20.16%	588,888 $14.7 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $4.48 Million - $7.28 Million	490,077 New	490,077 $6.17 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.